ALEC: ABC platform advances five neurodegeneration drugs with strong preclinical data and 2027 milestones
The discussion highlighted a strategic pivot to a validated neurodegeneration pipeline, leveraging the ABC platform for efficient brain delivery of multiple drug modalities. Key programs, including AL137 and Tau siRNA, are advancing with strong preclinical data, robust financial runway, and active…